|
 CREED
PETTIGREW, M.D.
Dr. Pettigrew is a professor in neurology at the University of
Kentucky College of Medicine, as well as the director of the
stroke program. He obtained his medical doctorate at the
University of Texas in Galveston in 1980 as well as his M.P.H.
(Health Services Administration) at the University of Texas
School of Public Health in Houston in 1981.
L. Creed Pettigrew, M.D., M.P.H.
Professor of Neurology
Director, Stroke Program
Sanders-Brown Center on Aging
101 Sanders-Brown Building
Lexington, KY 40536-0230
Tel: (859) 257-5560
Fax: (859) 257-8990
E-mail: cpettigrew@aging.coa.uky.edu
RECENT PUBLICATIONS
Smith CD, Malcein M, Meurer K, Schmitt FA, Markesbery WR, Pettigrew
LC, MRI temporal lobe volume measures and neuropsychologic
function in Alzheimer's disease. J Neuroimaging
1999;9(1):2-9.
Clark WM, Warach S, Pettigrew LC, Gammans RE,
Sabounjian LA. Arandomized dose response trial of citicoline in
acute ischemic stroke patients. Neurology
1997;49:671-678.
Minger SL, Geddes JW, Holtz ML, Craddock SD, Whiteheart SW,
Siman RG, Pettigrew LC, Glutamate receptor anagonists
inhibit calpain-mediated cytoskeletal proteolysis in focal
cerebral ischemia. Brain Res 1998;810:181-199.
Dubal DB, Dashon ML, Pettigrew LC, Ren JM, Finklestein
SP, Rau SW, Wise PM. Estradiol protects against ischemic injury.
J Cereb Blood Flow Metab 1998:18:1253-1258.
Pettigrew LC, Bieber F, Lettieri J, Wermeling DP,
Schmitt FA, Tikhtman AJ, Ashford JW, Smith CD, Wekstein DR,
Markesbery WR, Orazem J, Ruzicka BB, Mas J, Gulanski B. A study
of the pharmacokinetics, pharmacodynamics and safety of
metrifonate in Alzheimer's Disease patients. J Clin Pharmacol
1998;38;236-245.
Clark WM, Warach S, Pettigrew LC, Gammans RE,
Sabounjian LA. Arandomized dose response trial of citicoline in
acute ischemic stroke patients. Neurology
1997;49:671-678. |
